Michael Shleifer
Chief Executive Officer at BIOTECH ACQUISITION COMPANY
Profile
Michael Shleifer is the founder of Vanteres Pte Ltd.
(founded in 2016), SPRIM (founded in 2001), Sprim Ventures Pte Ltd.
(founded in 2015), and Sprim Global Investments Pte Ltd.
(founded in 2001).
He holds the title of Managing Partner at SPRIM, Sprim Ventures Pte Ltd., and Sprim Global Investments Pte Ltd.
Dr. Shleifer is also the founder of Travecta Therapeutics Pte Ltd.
Dr. Shleifer's current job(s) include Chairman & Chief Executive Officer at Biotech Acquisition Co., Director at Fibronostics Pte Ltd., Director at Vanteres Pte Ltd., Director at Phoska Biopharma Pte Ltd., Director at Nereus Therapeutics Pte Ltd., Director at Neurtheia Therapeutics Pte Ltd., and Director at Integrale Pte Ltd.
In terms of education, Dr. Shleifer graduated from Sciences Po and holds multiple doctorate degrees from Université de Paris 5 René Descartes.
Michael Shleifer active positions
| Companies | Position | Start |
|---|---|---|
| BIOTECH ACQUISITION COMPANY | Chief Executive Officer | 2020-08-31 |
Sprim Ventures Pte Ltd.
 Sprim Ventures Pte Ltd. Investment ManagersFinance Sprim Ventures Pte Ltd (Sprim Ventures) is a venture capital firm founded by Michael Shleifer, Ivan Jarry and Laurent Benissan in 2015. The firm is headquartered in Singapore. | Founder | 2014-12-31 |
| Sprim Global Investments Pte Ltd. | Founder | 2000-12-31 |
Fibronostics Pte Ltd.
 Fibronostics Pte Ltd. Information Technology ServicesTechnology Services Fibronostics Pte Ltd. develops and commercializes non-invasive diagnostic tests. It specializes in hepatology, nephrology, and metabolic conditions. The firm's products include LiverFACT and LiverFAST. The company is headquartered in Singapore. | Director/Board Member | - |
| Neurtheia Therapeutics Pte Ltd. | Director/Board Member | - |
Nereus Therapeutics Pte Ltd.
 Nereus Therapeutics Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Nereus Therapeutics Pte Ltd. engages in research and experimental development on biotechnology, and life and medical science. The company was founded on June 26, 2019 and is headquartered in Singapore. | Director/Board Member | - |
Phoska Biopharma Pte Ltd.
 Phoska Biopharma Pte Ltd. BiotechnologyHealth Technology Phoska Biopharma Pte Ltd. develops advancing new therapies for treating liver and metabolic conditions. The company is headquartered in Singapore. | Director/Board Member | - |
Vanteres Pte Ltd.
 Vanteres Pte Ltd. BiotechnologyHealth Technology Vanteres Pte Ltd. develops diagnostics and treatment solutions. The firm also develops a Gen 1.0 medical food product. The company was founded by David Silver, Michael Shleifer, and Laurent Benissan in 2016 and is headquartered in Singapore. | Director/Board Member | - |
| Integrale Pte Ltd. | Director/Board Member | - |
| ░░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
Former positions of Michael Shleifer
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░ ░░░ ░░░░ | ░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░ | - |
Training of Michael Shleifer
| Sciences Po | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Travecta Therapeutics Pte Ltd.
 Travecta Therapeutics Pte Ltd. Packaged SoftwareTechnology Services Travecta Therapeutics Pte Ltd. develops a novel chemistry platform for delivery of therapies to the brain. The company was founded by David L. Silver, Mahmood Ahmed, Michael Shleifer and Laurent Benissan and is headquartered in Singapore. | Technology Services |
Sprim Ventures Pte Ltd.
Sprim Ventures Pte Ltd. Investment ManagersFinance Sprim Ventures Pte Ltd (Sprim Ventures) is a venture capital firm founded by Michael Shleifer, Ivan Jarry and Laurent Benissan in 2015. The firm is headquartered in Singapore. | Finance |
Vanteres Pte Ltd.
Vanteres Pte Ltd. BiotechnologyHealth Technology Vanteres Pte Ltd. develops diagnostics and treatment solutions. The firm also develops a Gen 1.0 medical food product. The company was founded by David Silver, Michael Shleifer, and Laurent Benissan in 2016 and is headquartered in Singapore. | Health Technology |
Biotech Acquisition Co.
 Biotech Acquisition Co. Financial ConglomeratesFinance Biotech Acquisition Co. is a blank check company, which engages in the effectuation of a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one business. The company was founded on September 3, 2020 and is headquartered in New York, NY. | Finance |
| Université de Paris 5 René Descartes | Consumer Services |
| Sprim Global Investments Pte Ltd. | |
Fibronostics Pte Ltd.
Fibronostics Pte Ltd. Information Technology ServicesTechnology Services Fibronostics Pte Ltd. develops and commercializes non-invasive diagnostic tests. It specializes in hepatology, nephrology, and metabolic conditions. The firm's products include LiverFACT and LiverFAST. The company is headquartered in Singapore. | Technology Services |
| Neurtheia Therapeutics Pte Ltd. | |
Nereus Therapeutics Pte Ltd.
Nereus Therapeutics Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Nereus Therapeutics Pte Ltd. engages in research and experimental development on biotechnology, and life and medical science. The company was founded on June 26, 2019 and is headquartered in Singapore. | Commercial Services |
Phoska Biopharma Pte Ltd.
Phoska Biopharma Pte Ltd. BiotechnologyHealth Technology Phoska Biopharma Pte Ltd. develops advancing new therapies for treating liver and metabolic conditions. The company is headquartered in Singapore. | Health Technology |
| Integrale Pte Ltd. | |
SPRIM
 SPRIM Medical/Nursing ServicesHealth Services SPRIM provides health prevention research and information consulting services. It offers research and clinical services, health marketing and communications, issue and quality management, and regulatory and scientific affairs services. The company was founded by Michael Shleifer, Ivan Jarry and Olivier Shleifer and is headquartered in Paris, France. | Health Services |
- Stock Market
- Insiders
- Michael Shleifer